1H-MR spectroscopy. Methods and applications in diagnostics and assessment of operative and conservative treatment schedules in epilepsies;1H-MR-spektroskopie. Methoden und anwendungen in der diagnostik und beurteilung operativer und konservativer therapiestrategien bei epilepsien

Nervenarzt

Volumn 75, Issue 10, 2004, Pages 970-983

  Hammen, T ^a   Stefan, H ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

1H MRS; Differentiation of mesial TLE from lateral (neocortical) TLE; Epilepsy; Multimodal focus localization; Postoperative outcome; Therapy monitoring by 1H MRS

Indexed keywords

ARTICLE; CONSERVATIVE TREATMENT; EPILEPSY; HEMISPHERIC DOMINANCE; HUMAN; LATERAL TEMPORAL LOBE EPILEPSY; MESIAL TEMPORAL LOBE EPILEPSY; MULTIMODAL FOCUS LOCALIZATION; NEUROSURGERY; PATIENT MONITORING; POSTOPERATIVE PERIOD; PROTON NUCLEAR MAGNETIC RESONANCE; TECHNIQUE; TEMPORAL LOBE EPILEPSY; ALGORITHM; BRAIN; BRAIN MAPPING; CLASSIFICATION; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

ANTICONVULSIVE AGENT; PROTON;

ALGORITHMS; ANTICONVULSANTS; BRAIN; BRAIN MAPPING; DIAGNOSIS, DIFFERENTIAL; EPILEPSY, TEMPORAL LOBE; GUIDELINES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEUROSURGICAL PROCEDURES; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; PROTONS; TREATMENT OUTCOME;

EID: 7944225908     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1727-2     Document Type: Article

References (42)

1. Achten E, Boon P, Van De Kerckhove T et al. (1997) Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy. AJNR Am J Neuroradiol 18:1131-1139
2. Brooks WM, Friedman SD, Stidley CA (1999) Reproducibility of 1H-MRS in vivo. Magn Reson Med 41:193-197
3. Cendes F, Andermann F, Dubeau F et al. (1995) Proton magnetic resonance spectroscopic images and MRI volumetric studies for lateralization of temporal lobe epilepsy. Magn Reson Imaging 13:1187-1191
4. Cendes F, Andermann F, Dubeau F et al. (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49:1525-1533
5. Cendes F, Caramanos Z, Andermann F et al. (1997) Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 42:737-746
6. Choi CG, Frahm J (1999) Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med 41:204-207
7. Connelly A, Jackson GD, Duncan JS et al. (1994) Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 44:1411-1417
8. Connelly A, Van Paesschen W, Porter DA et al. (1998) Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology 51:61-66
9. Dautry C, Vaufrey F, Brouillet E et al. (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 20:789-799
10. De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 34:721-727
11. Garcia PA, Laxer KD, van der Grand J et al. (1995) Proton magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy. Ann Neurol 37:279-281
12. Hammen T, Stefan H, Pauli E et al. (2004) 1H-MR spectroscopy: a promising method in distinguishing subgroups in temporal lobe epilepsy? J Neurol Sci (in press)
13. Hugg JW, Laxer KD, Matson GB et al. (1993) Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 34:788-794
14. Knowlton RC, Laxer KD, Ende G et al. (1997) Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol 42:829-837
15. Kuzniecky R, Burgard S, Faught E et al. (1993) Predictive value of magnetic resonance imaging in temporal lobe epilepsy surgery. Arch Neurol 50:65-69
16. Kuzniecky R, Hugg JW, Hetherington H et al. (1998) Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 51:66-71
17. Kuzniecky R, Hugg J, Hetherington H et al. (1999) Predictive value of 1H MRSI for outcome in temporal lobectomy. Neurology 53:694-698
18. Li LM, Caramanos Z, Cendes F et al. (2000) Lateralization of temporal lobe epilepsy (TLE) and discrimination of TLE from extra-TLE using pattern analysis of magnetic resonance spectroscopic and volumetric data. Epilepsia 41:832-842
19. Lundbom N, Gaily E, Vuori K et al. (2001) Proton spectroscopic imaging shows abnormalities in glial and neuronal cell pools in frontal lobe epilepsy. Epilepsia 42:1507-1514
20. Margerison JH, Corsellis JA (1966) Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 89:499-530
21. Mory SB, Li LM, Guerreiro CA et al. (2003) Thalamic dysfunction in juvenile myoclonic epilepsy: a proton MRS study. Epilepsia 44:1402-1405
22. Mueller SG, Weber OM, Duc CO et al. (2001) Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics. Epilepsia 42:29-40
23. Mueller SG, Weber OM, Duc CO et al. (2003) Effects of vigabatrin on brain GABA+/Cr signals in focus-distant and focus-near brain regions monitored by 1H-NMR spectroscopy. Eur J Neurol 10:45-52
24. Nakano M, Ueda H, Li JY et al. (1998) Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: an index of neuronal survival. Ann Neurol 44:334-340
25. Ng TC, Comair YG, Xue M et al. (1994) Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology 193:465-472
26. Petroff OA, Behar KL, Mattson RH et al. (1996) Human brain γ-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy. J Neurochem 67:2399-2404
27. Petroff OA, Rothman DL, Behar KL et al. (1996) Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 47:1567-1571
28. Petroff OA, Rothman DL, Behar KL et al. (1996) Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose. Neurology 46:1459-1463
29. Petroff OA, Rothman DL, Behar KL et al. (1996) Low brain GABA level is associated with poor seizure control. Ann Neurol 40:908-911
30. Petroff OA, Hyder F, Rothman DL et al. (2000) Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients. Epilepsia 41:675-680
31. Petroff OA, Hyder F, Rothman DL et al. (2001) Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 42:543-548
32. Savic I, Osterman Y, Helms G (2004) MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies. Neuroimage 21:163-172
33. Serles W, Li LM, Antel SB et al. (2001) Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy. Epilepsia 42:190-197
34. Simister RJ, McLean MA, Barker GJ et al. (2003) Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy. Neurology 61:897-902
35. Stanley JA, Cendes F, Dubeau F et al. (1998) Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy. Epilepsia 39:267-273
36. Stefan H (2003) Ictal signs - cerebral localization an propagation. Nervenarzt 74:527-536
37. Stefan H, Pauli E, Eberhardt KE et al. (2000) MRI spectroscopy, T2 relaxometry, and postoperative prognosis in cryptogenic temporal lobe epilepsy. Nervenarzt 71:282-287
38. Suhy J, Laxer KD, Capizzano AA et al. (2002) 1H MRSI predicts surgical outcome in MRI-negative temporal lobe epilepsy. Neurology 58:821-823
39. Urenjak J, Williams SR, Gadian DG et al. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981-989
40. Vermathen P, Ende G, Laxer KD et al. (1997) Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Ann Neurol 42:194-199
41. Woermann FG, McLean MA, Bartlett PA et al. (1999) Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 45:369-376
42. Woermann FG, McLean MA, Bartlett PA et al. (2001) Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy. Brain 124:427-436